secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lunai Bioworks Inc. (LNAI)
CIK:        0001527728
Form:       8-K
Filed at:   2024-09-17T23:59:59+00:00
Accession:  0001731122-24-001431
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Renovaro receives Nasdaq deficiency notice for bid price below $1; 180-day cure period
--------------------------------------------------------------------------------

- Nasdaq notified Renovaro on Sept 12, 2024 that stock failed minimum $1 bid price for 30 consecutive business days.
- Company has 180 calendar days (until March 11, 2025) to regain compliance by closing at or above $1 for 10 consecutive days.
- If not cured, Renovaro may qualify for an additional 180-day period by meeting other listing standards.
- Stock continues trading under symbol RENB; company is evaluating options to regain bid price compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1527728/000173112224001431/0001731122-24-001431-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1527728/000173112224001431/e5942_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001731122-24-001431

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer